drugset / Trial / NCT04280874

Induction of Labor in Term Pregnancies With Unfavourable Cervix

NCT04280874

Phase 4 Completed 212 enrolled Clinical Hospital Merkur
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a prospective randomized trial comparing two prostaglandin E2 (dinoprostone) agents used for labor induction in pregnant women with term pregnancies and unfavorable cervix.

Timeline

Start
2018-12-10
Primary completion
2020-07-01
Completion
2020-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dinoprostone Other / unclassified 0.5 mg Other
Comparator Dinoprostone Other / unclassified 2 mg Other